June 30 2008  


Jos Lamers Brings Years of International Senior Management  

VEENENDAAL, THE NETHERLANDS (June 30, 2008) – Nucletron announced today the appointment of Jos Lamers as its new chief executive officer.  The appointment marks the next phase for the company following its successful management buy-out from Delft Instruments in August 2007, which created an independent company fully dedicated to radiation oncology.
 
Since its inception in 1974, Nucletron has operated several entities in the field of radiation oncology throughout the world.  The consolidation of the various entities into one focused company has further established Nucletron as a leader in this rapidly changing field.

Jos Lamers, a highly experienced international business executive, has a proven track record in life sciences and business-to-business fields.Prior to joining Nucletron, he held senior management and board positions at Numico, Europe’s top manufacture of baby and infant related food products, and currently is a member of the Executive Board at Eurofins Scientific, the leading international laboratory group offering quality testing and support services.
 
“I am excited to join Nucletron as the  CEO of this global leader in radiation oncology,” said Jos Lamers. “The strong management team and innovative approach to product development and delivery allow me to look forward to driving its performance further.”
With the appointment of Jos Lamers as CEO, the managing board of Nucletron is complete, with Jeroen Cammeraat as chief operating officer and Jan Sigger as chief financial officer. 

Headquartered in the Netherlands, Nucletron delivers customized solutions to more than 3,000 institutions in more than 120 countries, equating to global sales of €120 million ($180 million), with operating profit levels that rank in the upper quartile of the industry.  Worldwide, Nucletron has offices in 16 countries, including a production and R&D facility in The Netherlands, R&D centers in Uppsala, Sweden and Oslo, Norway and sales, marketing, service and support operations in Europe, Asia, Australia and North America.

The chairman of the supervisory board of Nucletron, Rob Westerhof, who has held senior positions in Asia and in the USA for Philips Medical Systems and Philips Electronics, commented on the appointment, "We are very pleased to have Jos Lamers join Nucletron as CEO. With his broad international experience I am sure that he will make a significant contribution to the company’s performance.”

About Nucletron
Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care.  Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services.  Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams – reconfiguring traditional boundaries between customer and solution provider.  Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians.  For more information, visit http://www.nucletron.com/.